D. Braun

发表

Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC).

J. Pujol, J. Trédaniel, E. Quoix, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer.

R. Gelber, B. Gusterson, A. Goldhirsch, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Le cancer bronchique primitif du sujet âgé en France

J. Piquet, B. Delclaux, M. Zureik, 2004 .

French phase III trial of preoperative chemotherapy (PCT) in resectable stage I (except T1N0), II, IIIa non-small cell lung cancer (NSCLC)

E. Lemarié, B. Milleron, S. Chevret, 2000 .

Similar survival rates with first-line gefitinib, gemcitabine, or docetaxel in a randomized phase II trial in elderly patients with advanced non-small cell lung cancer and a poor performance status (IFCT-0301).

B. Milleron, O. Molinier, D. Moro-Sibilot, 2015, Journal of geriatric oncology.

[Management and outcome of French elderly patients with lung cancer: an IFCT survey].

B. Milleron, P. Souquet, P. Girard, 2010, Revue des maladies respiratoires.

Long-term results of the French randomized trial comparing neoadjuvant chemotherapy followed by surgery versus surgery alone in resectable non-small cell lung cancer.

E. Lemarié, B. Milleron, D. Moro-Sibilot, 2010 .

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.

N. Girard, E. Devin, J. Muir, 2022, The Lancet. Oncology.

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.

M. Buyse, R. Ramlau, E. Stoelben, 2011, The Lancet. Oncology.

Complete response following preoperative chemotherapy for resectable non-small cell lung cancer: accuracy of clinical assessment using the French trial database.

B. Milleron, D. Moro-Sibilot, E. Quoix, 2005, Chest.

O-211 5-year results of the French randomized study comparing preoperative chemotherapy followed by surgery and primary surgery in resectable stage I (except T1N0), II and IIIA non-small cell lung cancer

E. Lemarié, B. Milleron, D. Moro-Sibilot, 2003 .

An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

P. Hainaut, B. Milleron, E. Brambilla, 2012, Clinical Cancer Research.

Preoperative C hemotherapy F ollowed b y S urgery C ompared With P rimary S urgery i n R esectable S tage I ( Except T1N0), I I, a nd I IIa N on-Small-Cell L ung C ancer

E. Lemarié, B. Milleron, L. Thiberville, 2002 .

Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer.

E. Lemarié, B. Milleron, L. Thiberville, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: long-term follow up on IBCSG Trial IX.

R. Gelber, B. Gusterson, A. Goldhirsch, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT 0002 trial).

E. Lemarié, B. Milleron, O. Molinier, 2013, European journal of cancer.

Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin.

E. Lemarié, B. Milleron, D. Spaeth, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

1273OResults of the phase III IFCT-0302 trial assessing minimal versus CT-scan-based follow-up for completely resected non-small cell lung cancer (NSCLC)

E. Devin, J. Lafitte, J. Trédaniel, 2017 .

Long-duration, weekly treatment with gemcitabine plus vinorelbine for non-small cell lung cancer: a multicenter phase II study.

B. Milleron, E. Quoix, A. Depierre, 2006, Lung cancer.

IFCT0002 phase III study comparing a preoperative (PRE) and a perioperative (PERI) chemotherapy with two different CT regimens in resectable non-small cell lung cancer (NSCLC): Early results

B. Milleron, J. Pujol, E. Quoix, 2007 .

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302).

E. Devin, J. Lafitte, J. Trédaniel, 2012 .

Results of the IFCT 0002 phase III study comparing a preoperative and a perioperative chemotherapy (CT) with two different CT regimens in resectable non-small cell lung cancer (NSCLC).

B. Milleron, J. Pujol, E. Quoix, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.